![](https://investorshub.advfn.com/uicon/32497.png?cb=1548411816)
Tuesday, April 07, 2015 8:37:32 PM
Plus no mention of the product that is 1-2 years out for osteoarthritis of the knee.
Article claims CBMG evaluation was based on Car-t product which they purchased for 1.8 million, when in reality majority of the company's evaluation is based on the progress of the osteoarthritis product.
It is going to be interesting to see how company responds in am, and how bad the final fall out will be.
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM